

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.61880884 |
| 2 | protein insertion into membrane (GO:0051205) | 4.41129396 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.25024806 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 4.25024806 |
| 5 | ribosomal small subunit assembly (GO:0000028) | 4.21539689 |
| 6 | ATP synthesis coupled proton transport (GO:0015986) | 4.20164495 |
| 7 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.20164495 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 4.09062218 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.09062218 |
| 10 | DNA deamination (GO:0045006) | 4.07737101 |
| 11 | metallo-sulfur cluster assembly (GO:0031163) | 3.92332644 |
| 12 | iron-sulfur cluster assembly (GO:0016226) | 3.92332644 |
| 13 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.78780956 |
| 14 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.78381651 |
| 15 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.77073787 |
| 16 | GTP biosynthetic process (GO:0006183) | 3.74644759 |
| 17 | base-excision repair, AP site formation (GO:0006285) | 3.65342947 |
| 18 | chaperone-mediated protein transport (GO:0072321) | 3.62350133 |
| 19 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.59541090 |
| 20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.59541090 |
| 21 | viral transcription (GO:0019083) | 3.56538112 |
| 22 | deoxyribonucleotide catabolic process (GO:0009264) | 3.55386853 |
| 23 | aromatic amino acid family catabolic process (GO:0009074) | 3.51332004 |
| 24 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.51050008 |
| 25 | protein maturation by protein folding (GO:0022417) | 3.50567955 |
| 26 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 3.50564952 |
| 27 | UTP biosynthetic process (GO:0006228) | 3.49143444 |
| 28 | inner mitochondrial membrane organization (GO:0007007) | 3.43170561 |
| 29 | negative regulation of B cell apoptotic process (GO:0002903) | 3.42725721 |
| 30 | translational termination (GO:0006415) | 3.42347857 |
| 31 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.41228587 |
| 32 | protein targeting to ER (GO:0045047) | 3.40831278 |
| 33 | glycine metabolic process (GO:0006544) | 3.40690673 |
| 34 | cotranslational protein targeting to membrane (GO:0006613) | 3.39406053 |
| 35 | serine family amino acid biosynthetic process (GO:0009070) | 3.34849557 |
| 36 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.34627525 |
| 37 | cysteine metabolic process (GO:0006534) | 3.33590602 |
| 38 | deoxyribose phosphate catabolic process (GO:0046386) | 3.31082880 |
| 39 | protein localization to endoplasmic reticulum (GO:0070972) | 3.27006081 |
| 40 | protein complex biogenesis (GO:0070271) | 3.25161748 |
| 41 | sulfur amino acid catabolic process (GO:0000098) | 3.25034769 |
| 42 | glyoxylate metabolic process (GO:0046487) | 3.22909191 |
| 43 | regulation of mitochondrial translation (GO:0070129) | 3.20854387 |
| 44 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.18938907 |
| 45 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.18754682 |
| 46 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.18068982 |
| 47 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.18068982 |
| 48 | tRNA modification (GO:0006400) | 3.17960034 |
| 49 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.17831188 |
| 50 | translational elongation (GO:0006414) | 3.16761053 |
| 51 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.16258225 |
| 52 | indole-containing compound catabolic process (GO:0042436) | 3.13115420 |
| 53 | indolalkylamine catabolic process (GO:0046218) | 3.13115420 |
| 54 | tryptophan catabolic process (GO:0006569) | 3.13115420 |
| 55 | UTP metabolic process (GO:0046051) | 3.12599904 |
| 56 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.10882249 |
| 57 | kynurenine metabolic process (GO:0070189) | 3.08933560 |
| 58 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.07919776 |
| 59 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.07919776 |
| 60 | NADH dehydrogenase complex assembly (GO:0010257) | 3.07919776 |
| 61 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.04139795 |
| 62 | L-serine metabolic process (GO:0006563) | 3.03537637 |
| 63 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.01902736 |
| 64 | UV protection (GO:0009650) | 3.01129734 |
| 65 | CTP biosynthetic process (GO:0006241) | 3.00910247 |
| 66 | CTP metabolic process (GO:0046036) | 3.00910247 |
| 67 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.99616996 |
| 68 | serine family amino acid metabolic process (GO:0009069) | 2.99264113 |
| 69 | sequestering of actin monomers (GO:0042989) | 2.97277072 |
| 70 | tryptophan metabolic process (GO:0006568) | 2.95351050 |
| 71 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.94406677 |
| 72 | pyrimidine nucleoside salvage (GO:0043097) | 2.93387233 |
| 73 | pyrimidine-containing compound salvage (GO:0008655) | 2.93387233 |
| 74 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.91826543 |
| 75 | intestinal cholesterol absorption (GO:0030299) | 2.90953896 |
| 76 | aldehyde catabolic process (GO:0046185) | 2.90662672 |
| 77 | electron transport chain (GO:0022900) | 2.90407456 |
| 78 | respiratory electron transport chain (GO:0022904) | 2.90397339 |
| 79 | mannosylation (GO:0097502) | 2.88027608 |
| 80 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.87851426 |
| 81 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.86918339 |
| 82 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.86588993 |
| 83 | Golgi transport vesicle coating (GO:0048200) | 2.86571247 |
| 84 | COPI coating of Golgi vesicle (GO:0048205) | 2.86571247 |
| 85 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.85923237 |
| 86 | pseudouridine synthesis (GO:0001522) | 2.85863816 |
| 87 | pentose metabolic process (GO:0019321) | 2.84389023 |
| 88 | positive regulation of T cell apoptotic process (GO:0070234) | 2.83104885 |
| 89 | valine metabolic process (GO:0006573) | 2.82369543 |
| 90 | ribosomal small subunit biogenesis (GO:0042274) | 2.81196841 |
| 91 | signal peptide processing (GO:0006465) | 2.78411487 |
| 92 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.78245212 |
| 93 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.77265643 |
| 94 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.76796152 |
| 95 | nucleoside salvage (GO:0043174) | 2.76790663 |
| 96 | cytochrome complex assembly (GO:0017004) | 2.75715310 |
| 97 | aromatic amino acid family metabolic process (GO:0009072) | 2.74456667 |
| 98 | high-density lipoprotein particle remodeling (GO:0034375) | 2.72922631 |
| 99 | pentose-phosphate shunt (GO:0006098) | 2.71848241 |
| 100 | viral life cycle (GO:0019058) | 2.71709271 |
| 101 | bile acid biosynthetic process (GO:0006699) | 2.71605113 |
| 102 | cellular response to interferon-beta (GO:0035458) | 2.70776526 |
| 103 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.70440163 |
| 104 | tetrahydrofolate metabolic process (GO:0046653) | 2.69237769 |
| 105 | protein targeting to mitochondrion (GO:0006626) | 2.68649357 |
| 106 | cellular response to exogenous dsRNA (GO:0071360) | 2.68642180 |
| 107 | proline biosynthetic process (GO:0006561) | 2.68475584 |
| 108 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.68353857 |
| 109 | protein carboxylation (GO:0018214) | 2.68353857 |
| 110 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.68013959 |
| 111 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.66381723 |
| 112 | peptidyl-histidine modification (GO:0018202) | 2.65928235 |
| 113 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.65536169 |
| 114 | serine family amino acid catabolic process (GO:0009071) | 2.65129559 |
| 115 | establishment of protein localization to mitochondrion (GO:0072655) | 2.64589039 |
| 116 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 2.62954513 |
| 117 | alpha-linolenic acid metabolic process (GO:0036109) | 2.60906792 |
| 118 | tRNA processing (GO:0008033) | 2.60616553 |
| 119 | regulation of cholesterol esterification (GO:0010872) | 2.60380896 |
| 120 | urea metabolic process (GO:0019627) | 2.60204413 |
| 121 | urea cycle (GO:0000050) | 2.60204413 |
| 122 | homocysteine metabolic process (GO:0050667) | 2.59659089 |
| 123 | ATP biosynthetic process (GO:0006754) | 2.59215259 |
| 124 | regulation of B cell apoptotic process (GO:0002902) | 2.59113189 |
| 125 | translational initiation (GO:0006413) | 2.59078968 |
| 126 | respiratory chain complex IV assembly (GO:0008535) | 2.59077181 |
| 127 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.58997407 |
| 128 | termination of RNA polymerase III transcription (GO:0006386) | 2.58997407 |
| 129 | mitochondrial calcium ion transport (GO:0006851) | 2.58702334 |
| 130 | negative regulation of fibrinolysis (GO:0051918) | 2.56567811 |
| 131 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.56291361 |
| 132 | deoxyribose phosphate metabolic process (GO:0019692) | 2.55600130 |
| 133 | cellular component biogenesis (GO:0044085) | 2.54570691 |
| 134 | viral protein processing (GO:0019082) | 2.54231435 |
| 135 | nucleotide transmembrane transport (GO:1901679) | 2.53769968 |
| 136 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.51678090 |
| 137 | NADPH regeneration (GO:0006740) | 2.51486039 |
| 138 | nitrogen cycle metabolic process (GO:0071941) | 2.50808634 |
| 139 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.50355930 |
| 140 | cellular protein complex disassembly (GO:0043624) | 2.50314580 |
| 141 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.48888747 |
| 142 | folic acid metabolic process (GO:0046655) | 2.48087273 |
| 143 | maturation of SSU-rRNA (GO:0030490) | 2.47666769 |
| 144 | GDP-mannose metabolic process (GO:0019673) | 2.47489808 |
| 145 | nucleotide salvage (GO:0043173) | 2.46525513 |
| 146 | formation of translation preinitiation complex (GO:0001731) | 2.46200382 |
| 147 | cellular modified amino acid catabolic process (GO:0042219) | 2.46072663 |
| 148 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.45960649 |
| 149 | imidazole-containing compound metabolic process (GO:0052803) | 2.45472299 |
| 150 | protein retention in ER lumen (GO:0006621) | 2.44034743 |
| 151 | response to interferon-beta (GO:0035456) | 2.43993782 |
| 152 | proline metabolic process (GO:0006560) | 2.42705291 |
| 153 | phospholipid efflux (GO:0033700) | 2.41757901 |
| 154 | protein-lipid complex remodeling (GO:0034368) | 2.41570267 |
| 155 | macromolecular complex remodeling (GO:0034367) | 2.41570267 |
| 156 | plasma lipoprotein particle remodeling (GO:0034369) | 2.41570267 |
| 157 | one-carbon metabolic process (GO:0006730) | 2.41190716 |
| 158 | pteridine-containing compound metabolic process (GO:0042558) | 2.40814722 |
| 159 | translation (GO:0006412) | 2.39700840 |
| 160 | amino-acid betaine metabolic process (GO:0006577) | 2.39067884 |
| 161 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.36463429 |
| 162 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.36463429 |
| 163 | alpha-amino acid catabolic process (GO:1901606) | 2.35934256 |
| 164 | reverse cholesterol transport (GO:0043691) | 2.35552958 |
| 165 | regulation of triglyceride catabolic process (GO:0010896) | 2.35409711 |
| 166 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.35282490 |
| 167 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.35276500 |
| 168 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.35276500 |
| 169 | regulation of protein activation cascade (GO:2000257) | 2.34923880 |
| 170 | sulfur amino acid biosynthetic process (GO:0000097) | 2.34389337 |
| 171 | tyrosine metabolic process (GO:0006570) | 2.33822284 |
| 172 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.33689940 |
| 173 | lysine metabolic process (GO:0006553) | 2.33607449 |
| 174 | lysine catabolic process (GO:0006554) | 2.33607449 |
| 175 | folic acid-containing compound metabolic process (GO:0006760) | 2.33266997 |
| 176 | ethanol oxidation (GO:0006069) | 2.32046504 |
| 177 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.31838406 |
| 178 | bile acid metabolic process (GO:0008206) | 2.31540029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.27035219 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.33508555 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.82478974 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.82317785 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.76739326 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.74739246 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.67858915 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.64348291 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.43356570 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.36549506 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.29209874 |
| 12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.25403386 |
| 13 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.24920687 |
| 14 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.21588358 |
| 15 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.21558452 |
| 16 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.11577228 |
| 17 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.08874237 |
| 18 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.08629658 |
| 19 | BCL6_27268052_Chip-Seq_Bcells_Human | 2.03532028 |
| 20 | P68_20966046_ChIP-Seq_HELA_Human | 2.00896015 |
| 21 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 2.00436983 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.99161179 |
| 23 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.97475282 |
| 24 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.96166082 |
| 25 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.96151696 |
| 26 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.94964714 |
| 27 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.92985245 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.90612410 |
| 29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89199055 |
| 30 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.81777284 |
| 31 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78613591 |
| 32 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.77461342 |
| 33 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.76590129 |
| 34 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.72297083 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69184463 |
| 36 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.67362762 |
| 37 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.66483900 |
| 38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.64414457 |
| 39 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.63488220 |
| 40 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.60402251 |
| 41 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.60218713 |
| 42 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.58927130 |
| 43 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.58280371 |
| 44 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.57112938 |
| 45 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.55539146 |
| 46 | MYC_22102868_ChIP-Seq_BL_Human | 1.55502332 |
| 47 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.54505320 |
| 48 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.53673870 |
| 49 | MAF_26560356_Chip-Seq_TH2_Human | 1.53539588 |
| 50 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.52784070 |
| 51 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.50624777 |
| 52 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.50055882 |
| 53 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.49535648 |
| 54 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.48142748 |
| 55 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.47574899 |
| 56 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.47539355 |
| 57 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.46603387 |
| 58 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.46225720 |
| 59 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.44535797 |
| 60 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43895285 |
| 61 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.43757581 |
| 62 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.43248815 |
| 63 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.43092453 |
| 64 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.42734497 |
| 65 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.42693928 |
| 66 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42196513 |
| 67 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.41468027 |
| 68 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.41373329 |
| 69 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.39736406 |
| 70 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.39503752 |
| 71 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.37618097 |
| 72 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.36663516 |
| 73 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.35522197 |
| 74 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.35296154 |
| 75 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.35223852 |
| 76 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.34810275 |
| 77 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.34570228 |
| 78 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32013001 |
| 79 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.31862235 |
| 80 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.31338184 |
| 81 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.30814766 |
| 82 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.30781950 |
| 83 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.29559679 |
| 84 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.29555083 |
| 85 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.29405003 |
| 86 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.29178451 |
| 87 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.28170269 |
| 88 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.28098234 |
| 89 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.27688232 |
| 90 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.26785250 |
| 91 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.24840419 |
| 92 | SA1_27219007_Chip-Seq_Bcells_Human | 1.24505270 |
| 93 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.23991937 |
| 94 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.22089510 |
| 95 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.21809717 |
| 96 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.21453455 |
| 97 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.17893277 |
| 98 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.17421797 |
| 99 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.17215354 |
| 100 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16594885 |
| 101 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.15629182 |
| 102 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.15168373 |
| 103 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.15017646 |
| 104 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.14507919 |
| 105 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.13637621 |
| 106 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.12736464 |
| 107 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.12246247 |
| 108 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.12003511 |
| 109 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.11897126 |
| 110 | P300_27268052_Chip-Seq_Bcells_Human | 1.11369617 |
| 111 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.11054551 |
| 112 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.11021766 |
| 113 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.10369326 |
| 114 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.10191148 |
| 115 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09824466 |
| 116 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.09783897 |
| 117 | MAF_26560356_Chip-Seq_TH1_Human | 1.09452998 |
| 118 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07889995 |
| 119 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07672803 |
| 120 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.07614681 |
| 121 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.06601208 |
| 122 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.06380993 |
| 123 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.06304503 |
| 124 | GATA1_22025678_ChIP-Seq_K562_Human | 1.05685266 |
| 125 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.04771381 |
| 126 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04117718 |
| 127 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03178994 |
| 128 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.02129407 |
| 129 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.01833851 |
| 130 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.01522312 |
| 131 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00186342 |
| 132 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.99844919 |
| 133 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.99607464 |
| 134 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.99481766 |
| 135 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.98269255 |
| 136 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.97512062 |
| 137 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.97379258 |
| 138 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.95709583 |
| 139 | UTX_26944678_Chip-Seq_JUKART_Human | 0.94542691 |
| 140 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93993771 |
| 141 | MYB_26560356_Chip-Seq_TH1_Human | 0.93265921 |
| 142 | MYB_26560356_Chip-Seq_TH2_Human | 0.92800137 |
| 143 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.91944854 |
| 144 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.91909141 |
| 145 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91203904 |
| 146 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.91181906 |
| 147 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.91176474 |
| 148 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90430409 |
| 149 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.90396666 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.26085884 |
| 2 | MP0005360_urolithiasis | 3.88906250 |
| 3 | MP0005365_abnormal_bile_salt | 3.64579437 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 3.41139825 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.25346375 |
| 6 | MP0009840_abnormal_foam_cell | 3.09293867 |
| 7 | MP0005083_abnormal_biliary_tract | 2.83932744 |
| 8 | MP0000372_irregular_coat_pigmentation | 2.64031856 |
| 9 | MP0003136_yellow_coat_color | 2.61852497 |
| 10 | MP0001666_abnormal_nutrient_absorption | 2.44344581 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.32532946 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.30684414 |
| 13 | MP0003186_abnormal_redox_activity | 2.15934289 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.02287022 |
| 15 | MP0009785_altered_susceptibility_to | 2.01892216 |
| 16 | MP0000685_abnormal_immune_system | 2.01038379 |
| 17 | MP0003436_decreased_susceptibility_to | 1.98039409 |
| 18 | MP0001986_abnormal_taste_sensitivity | 1.89288323 |
| 19 | MP0000678_abnormal_parathyroid_gland | 1.85782267 |
| 20 | MP0010329_abnormal_lipoprotein_level | 1.82845919 |
| 21 | MP0005332_abnormal_amino_acid | 1.81354351 |
| 22 | MP0004858_abnormal_nervous_system | 1.81202960 |
| 23 | MP0003195_calcinosis | 1.77485456 |
| 24 | MP0003252_abnormal_bile_duct | 1.75286330 |
| 25 | MP0002163_abnormal_gland_morphology | 1.64798869 |
| 26 | MP0009278_abnormal_bone_marrow | 1.64330728 |
| 27 | MP0005025_abnormal_response_to | 1.62108735 |
| 28 | MP0000609_abnormal_liver_physiology | 1.58319639 |
| 29 | MP0000015_abnormal_ear_pigmentation | 1.58123481 |
| 30 | MP0003303_peritoneal_inflammation | 1.57916081 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 1.55768009 |
| 32 | MP0001764_abnormal_homeostasis | 1.55522653 |
| 33 | MP0005671_abnormal_response_to | 1.55288819 |
| 34 | MP0003693_abnormal_embryo_hatching | 1.54790453 |
| 35 | MP0005319_abnormal_enzyme/_coenzyme | 1.52270319 |
| 36 | MP0009643_abnormal_urine_homeostasis | 1.50771528 |
| 37 | MP0000013_abnormal_adipose_tissue | 1.50317214 |
| 38 | MP0003786_premature_aging | 1.50285709 |
| 39 | MP0008469_abnormal_protein_level | 1.50233567 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.49294242 |
| 41 | MP0000681_abnormal_thyroid_gland | 1.49182093 |
| 42 | MP0006054_spinal_hemorrhage | 1.45682714 |
| 43 | MP0002653_abnormal_ependyma_morphology | 1.43961173 |
| 44 | MP0005220_abnormal_exocrine_pancreas | 1.42548091 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.42264536 |
| 46 | MP0002148_abnormal_hypersensitivity_rea | 1.41585542 |
| 47 | MP0002396_abnormal_hematopoietic_system | 1.41418544 |
| 48 | MP0005174_abnormal_tail_pigmentation | 1.40658212 |
| 49 | MP0005171_absent_coat_pigmentation | 1.40469608 |
| 50 | MP0001853_heart_inflammation | 1.39913007 |
| 51 | MP0005000_abnormal_immune_tolerance | 1.39111894 |
| 52 | MP0001800_abnormal_humoral_immune | 1.38253203 |
| 53 | MP0004019_abnormal_vitamin_homeostasis | 1.37879569 |
| 54 | MP0001661_extended_life_span | 1.37453709 |
| 55 | MP0009379_abnormal_foot_pigmentation | 1.36999261 |
| 56 | MP0005058_abnormal_lysosome_morphology | 1.36403899 |
| 57 | MP0002419_abnormal_innate_immunity | 1.36363949 |
| 58 | MP0001845_abnormal_inflammatory_respons | 1.34893381 |
| 59 | MP0004381_abnormal_hair_follicle | 1.34564936 |
| 60 | MP0010155_abnormal_intestine_physiology | 1.34186333 |
| 61 | MP0003724_increased_susceptibility_to | 1.32400480 |
| 62 | MP0002723_abnormal_immune_serum | 1.31691270 |
| 63 | MP0003763_abnormal_thymus_physiology | 1.30091412 |
| 64 | MP0001919_abnormal_reproductive_system | 1.29893607 |
| 65 | MP0002452_abnormal_antigen_presenting | 1.27195341 |
| 66 | MP0003646_muscle_fatigue | 1.26537660 |
| 67 | MP0001905_abnormal_dopamine_level | 1.25631336 |
| 68 | MP0002102_abnormal_ear_morphology | 1.25328799 |
| 69 | MP0001663_abnormal_digestive_system | 1.25210278 |
| 70 | MP0000750_abnormal_muscle_regeneration | 1.25097853 |
| 71 | MP0000343_altered_response_to | 1.23858406 |
| 72 | MP0001790_abnormal_immune_system | 1.22862569 |
| 73 | MP0005387_immune_system_phenotype | 1.22862569 |
| 74 | MP0006036_abnormal_mitochondrial_physio | 1.21524124 |
| 75 | MP0002166_altered_tumor_susceptibility | 1.20299199 |
| 76 | MP0003315_abnormal_perineum_morphology | 1.19769939 |
| 77 | MP0000598_abnormal_liver_morphology | 1.19731020 |
| 78 | MP0000003_abnormal_adipose_tissue | 1.19527828 |
| 79 | MP0002420_abnormal_adaptive_immunity | 1.19264224 |
| 80 | MP0001819_abnormal_immune_cell | 1.18193813 |
| 81 | MP0001727_abnormal_embryo_implantation | 1.17465941 |
| 82 | MP0005084_abnormal_gallbladder_morpholo | 1.16850754 |
| 83 | MP0001873_stomach_inflammation | 1.16682501 |
| 84 | MP0004947_skin_inflammation | 1.16266501 |
| 85 | MP0000689_abnormal_spleen_morphology | 1.15369142 |
| 86 | MP0005410_abnormal_fertilization | 1.14854615 |
| 87 | MP0002118_abnormal_lipid_homeostasis | 1.14744711 |
| 88 | MP0006035_abnormal_mitochondrial_morpho | 1.14567437 |
| 89 | MP0003656_abnormal_erythrocyte_physiolo | 1.14334667 |
| 90 | MP0003878_abnormal_ear_physiology | 1.13225384 |
| 91 | MP0005377_hearing/vestibular/ear_phenot | 1.13225384 |
| 92 | MP0002405_respiratory_system_inflammati | 1.13164660 |
| 93 | MP0003868_abnormal_feces_composition | 1.12943657 |
| 94 | MP0009764_decreased_sensitivity_to | 1.12709474 |
| 95 | MP0000858_altered_metastatic_potential | 1.12101175 |
| 96 | MP0005167_abnormal_blood-brain_barrier | 1.12023220 |
| 97 | MP0000490_abnormal_crypts_of | 1.11973972 |
| 98 | MP0002277_abnormal_respiratory_mucosa | 1.09865389 |
| 99 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.09860946 |
| 100 | MP0004957_abnormal_blastocyst_morpholog | 1.08786282 |
| 101 | MP0002398_abnormal_bone_marrow | 1.08163504 |
| 102 | MP0002722_abnormal_immune_system | 1.07519525 |
| 103 | MP0000716_abnormal_immune_system | 1.07032770 |
| 104 | MP0003705_abnormal_hypodermis_morpholog | 1.06815916 |
| 105 | MP0005408_hypopigmentation | 1.06224102 |
| 106 | MP0002095_abnormal_skin_pigmentation | 1.05765325 |
| 107 | MP0006292_abnormal_olfactory_placode | 1.05467116 |
| 108 | MP0005636_abnormal_mineral_homeostasis | 1.05434132 |
| 109 | MP0010030_abnormal_orbit_morphology | 1.03151695 |
| 110 | MP0002429_abnormal_blood_cell | 1.02636626 |
| 111 | MP0009763_increased_sensitivity_to | 1.00802776 |
| 112 | MP0005397_hematopoietic_system_phenotyp | 0.98717171 |
| 113 | MP0001545_abnormal_hematopoietic_system | 0.98717171 |
| 114 | MP0002006_tumorigenesis | 0.97168411 |
| 115 | MP0005670_abnormal_white_adipose | 0.96894808 |
| 116 | MP0001533_abnormal_skeleton_physiology | 0.96510889 |
| 117 | MP0003172_abnormal_lysosome_physiology | 0.96426608 |
| 118 | MP0006082_CNS_inflammation | 0.95198726 |
| 119 | MP0005257_abnormal_intraocular_pressure | 0.91432251 |
| 120 | MP0005451_abnormal_body_composition | 0.91043892 |
| 121 | MP0005389_reproductive_system_phenotype | 0.89443503 |
| 122 | MP0010352_gastrointestinal_tract_polyps | 0.89175070 |
| 123 | MP0005551_abnormal_eye_electrophysiolog | 0.89028664 |
| 124 | MP0002136_abnormal_kidney_physiology | 0.87670990 |
| 125 | MP0004782_abnormal_surfactant_physiolog | 0.87171961 |
| 126 | MP0005075_abnormal_melanosome_morpholog | 0.86799400 |
| 127 | MP0002132_abnormal_respiratory_system | 0.84910985 |
| 128 | MP0002019_abnormal_tumor_incidence | 0.83305927 |
| 129 | MP0000538_abnormal_urinary_bladder | 0.81681281 |
| 130 | MP0005390_skeleton_phenotype | 0.81284658 |
| 131 | MP0001756_abnormal_urination | 0.81010090 |
| 132 | MP0005023_abnormal_wound_healing | 0.80538250 |
| 133 | MP0009642_abnormal_blood_homeostasis | 0.78990059 |
| 134 | MP0000537_abnormal_urethra_morphology | 0.78836240 |
| 135 | MP0005381_digestive/alimentary_phenotyp | 0.78723404 |
| 136 | MP0009765_abnormal_xenobiotic_induced | 0.77070356 |
| 137 | MP0003011_delayed_dark_adaptation | 0.75444106 |
| 138 | MP0002693_abnormal_pancreas_physiology | 0.74126084 |
| 139 | MP0009697_abnormal_copulation | 0.73380982 |
| 140 | MP0003866_abnormal_defecation | 0.73363909 |
| 141 | MP0008007_abnormal_cellular_replicative | 0.72516375 |
| 142 | MP0000358_abnormal_cell_content/ | 0.70000866 |
| 143 | MP0000465_gastrointestinal_hemorrhage | 0.69173826 |
| 144 | MP0005376_homeostasis/metabolism_phenot | 0.67138431 |
| 145 | MP0002877_abnormal_melanocyte_morpholog | 0.66847854 |
| 146 | MP0002933_joint_inflammation | 0.66677428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.95193252 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.05603221 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.92885133 |
| 4 | Mitochondrial inheritance (HP:0001427) | 3.91310026 |
| 5 | Hepatocellular necrosis (HP:0001404) | 3.68466584 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 3.64889336 |
| 7 | Increased intramyocellular lipid droplets (HP:0012240) | 3.61863086 |
| 8 | Increased muscle lipid content (HP:0009058) | 3.59911415 |
| 9 | Acute necrotizing encephalopathy (HP:0006965) | 3.58590763 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.49995249 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 3.49995249 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.49995249 |
| 13 | Hypoglycemic coma (HP:0001325) | 3.47948919 |
| 14 | Hypobetalipoproteinemia (HP:0003563) | 3.46945518 |
| 15 | Increased CSF lactate (HP:0002490) | 3.38846143 |
| 16 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.33265301 |
| 17 | Xanthomatosis (HP:0000991) | 3.31941454 |
| 18 | Acute encephalopathy (HP:0006846) | 3.20033374 |
| 19 | Prolonged partial thromboplastin time (HP:0003645) | 3.15721644 |
| 20 | Deep venous thrombosis (HP:0002625) | 3.13623246 |
| 21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.06496086 |
| 22 | Testicular atrophy (HP:0000029) | 3.05918176 |
| 23 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.00088413 |
| 24 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.99386587 |
| 25 | Renal Fanconi syndrome (HP:0001994) | 2.98606523 |
| 26 | Abnormality of the intrinsic pathway (HP:0010989) | 2.97430304 |
| 27 | Generalized aminoaciduria (HP:0002909) | 2.96638384 |
| 28 | Hyperammonemia (HP:0001987) | 2.91928886 |
| 29 | Progressive microcephaly (HP:0000253) | 2.90976122 |
| 30 | Abnormal number of erythroid precursors (HP:0012131) | 2.89374247 |
| 31 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.88600503 |
| 32 | Mesangial abnormality (HP:0001966) | 2.87928711 |
| 33 | Lactic acidosis (HP:0003128) | 2.82437691 |
| 34 | Congenital stationary night blindness (HP:0007642) | 2.77186082 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.77169692 |
| 36 | Abnormality of the common coagulation pathway (HP:0010990) | 2.76284821 |
| 37 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.75249252 |
| 38 | Reduced antithrombin III activity (HP:0001976) | 2.74999439 |
| 39 | Thrombocytosis (HP:0001894) | 2.72446895 |
| 40 | Lipid accumulation in hepatocytes (HP:0006561) | 2.71424747 |
| 41 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.68526189 |
| 42 | Increased hepatocellular lipid droplets (HP:0006565) | 2.67993801 |
| 43 | Vacuolated lymphocytes (HP:0001922) | 2.67330945 |
| 44 | Ketosis (HP:0001946) | 2.64833172 |
| 45 | Fat malabsorption (HP:0002630) | 2.62376205 |
| 46 | Joint hemorrhage (HP:0005261) | 2.58333079 |
| 47 | Ragged-red muscle fibers (HP:0003200) | 2.57099571 |
| 48 | Increased serum lactate (HP:0002151) | 2.56613716 |
| 49 | Progressive macrocephaly (HP:0004481) | 2.55731399 |
| 50 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.55639459 |
| 51 | Hyperlipoproteinemia (HP:0010980) | 2.53771894 |
| 52 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.52895775 |
| 53 | Dicarboxylic aciduria (HP:0003215) | 2.52895775 |
| 54 | Exercise intolerance (HP:0003546) | 2.52196517 |
| 55 | Reticulocytopenia (HP:0001896) | 2.51193724 |
| 56 | Hyperglycinuria (HP:0003108) | 2.49185953 |
| 57 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.48966742 |
| 58 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.46306179 |
| 59 | Rough bone trabeculation (HP:0100670) | 2.46276313 |
| 60 | Hypertensive crisis (HP:0100735) | 2.44855170 |
| 61 | Petechiae (HP:0000967) | 2.44334551 |
| 62 | Hypolipoproteinemia (HP:0010981) | 2.42759793 |
| 63 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.40438792 |
| 64 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.40438792 |
| 65 | Late onset (HP:0003584) | 2.40426767 |
| 66 | Hyperbilirubinemia (HP:0002904) | 2.33612472 |
| 67 | Hyperglycinemia (HP:0002154) | 2.33564876 |
| 68 | Hepatic necrosis (HP:0002605) | 2.33166857 |
| 69 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.31407240 |
| 70 | Steatorrhea (HP:0002570) | 2.31155682 |
| 71 | Optic disc pallor (HP:0000543) | 2.30034721 |
| 72 | Abnormality of nucleobase metabolism (HP:0010932) | 2.29882477 |
| 73 | Prolonged neonatal jaundice (HP:0006579) | 2.29667390 |
| 74 | Abnormality of methionine metabolism (HP:0010901) | 2.27334176 |
| 75 | 3-Methylglutaconic aciduria (HP:0003535) | 2.27175570 |
| 76 | Ketoacidosis (HP:0001993) | 2.22964382 |
| 77 | Recurrent bacterial skin infections (HP:0005406) | 2.22906922 |
| 78 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.22789257 |
| 79 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.22789257 |
| 80 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.22789257 |
| 81 | Myositis (HP:0100614) | 2.21522487 |
| 82 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.20481365 |
| 83 | Abnormality of glycine metabolism (HP:0010895) | 2.20481365 |
| 84 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.19955131 |
| 85 | Hemorrhage of the eye (HP:0011885) | 2.16921000 |
| 86 | Eczematoid dermatitis (HP:0000976) | 2.16602614 |
| 87 | Complement deficiency (HP:0004431) | 2.16395261 |
| 88 | Increased serum ferritin (HP:0003281) | 2.14968228 |
| 89 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.14622053 |
| 90 | Pancreatitis (HP:0001733) | 2.13766659 |
| 91 | Respiratory difficulties (HP:0002880) | 2.13190124 |
| 92 | Cerebral palsy (HP:0100021) | 2.12518029 |
| 93 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.11987619 |
| 94 | Abnormality of magnesium homeostasis (HP:0004921) | 2.11482017 |
| 95 | Pustule (HP:0200039) | 2.10575186 |
| 96 | Recurrent abscess formation (HP:0002722) | 2.09782563 |
| 97 | Squamous cell carcinoma (HP:0002860) | 2.09610090 |
| 98 | Systemic lupus erythematosus (HP:0002725) | 2.09321454 |
| 99 | Poikiloderma (HP:0001029) | 2.07509859 |
| 100 | Microretrognathia (HP:0000308) | 2.07143735 |
| 101 | Macrocytic anemia (HP:0001972) | 2.06448737 |
| 102 | Abnormality of iron homeostasis (HP:0011031) | 2.06345663 |
| 103 | Lethargy (HP:0001254) | 2.06340197 |
| 104 | Aplastic anemia (HP:0001915) | 2.06302187 |
| 105 | Gingival bleeding (HP:0000225) | 2.04785824 |
| 106 | Abnormality of T cell physiology (HP:0011840) | 2.03503157 |
| 107 | IgM deficiency (HP:0002850) | 2.03240168 |
| 108 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.03169287 |
| 109 | Spastic diplegia (HP:0001264) | 2.03074742 |
| 110 | Exertional dyspnea (HP:0002875) | 2.02773269 |
| 111 | Multiple enchondromatosis (HP:0005701) | 2.02199940 |
| 112 | Type I transferrin isoform profile (HP:0003642) | 2.02130224 |
| 113 | Oral leukoplakia (HP:0002745) | 1.99702638 |
| 114 | Abnormality of serum amino acid levels (HP:0003112) | 1.98696688 |
| 115 | Abnormal trabecular bone morphology (HP:0100671) | 1.97636562 |
| 116 | Poor head control (HP:0002421) | 1.97593132 |
| 117 | Esophageal neoplasm (HP:0100751) | 1.97536124 |
| 118 | Neoplasm of head and neck (HP:0012288) | 1.97536124 |
| 119 | Abnormal protein glycosylation (HP:0012346) | 1.97450742 |
| 120 | Abnormal glycosylation (HP:0012345) | 1.97450742 |
| 121 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.97450742 |
| 122 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.97450742 |
| 123 | Beaking of vertebral bodies (HP:0004568) | 1.96426698 |
| 124 | Emotional lability (HP:0000712) | 1.96265652 |
| 125 | Conjugated hyperbilirubinemia (HP:0002908) | 1.95439654 |
| 126 | Delayed CNS myelination (HP:0002188) | 1.95077721 |
| 127 | Abnormality of purine metabolism (HP:0004352) | 1.94779510 |
| 128 | Abnormality of complement system (HP:0005339) | 1.94378047 |
| 129 | Cerebral edema (HP:0002181) | 1.94253198 |
| 130 | Chronic otitis media (HP:0000389) | 1.93555198 |
| 131 | Dysautonomia (HP:0002459) | 1.93504531 |
| 132 | Epistaxis (HP:0000421) | 1.93337085 |
| 133 | Increased cerebral lipofuscin (HP:0011813) | 1.93031085 |
| 134 | Respiratory failure (HP:0002878) | 1.92724944 |
| 135 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.91923362 |
| 136 | Nausea (HP:0002018) | 1.91618249 |
| 137 | Joint stiffness (HP:0001387) | 1.90771770 |
| 138 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.90225908 |
| 139 | Purpura (HP:0000979) | 1.89477320 |
| 140 | Pallor (HP:0000980) | 1.88924339 |
| 141 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.88210155 |
| 142 | Gout (HP:0001997) | 1.87712976 |
| 143 | Severe visual impairment (HP:0001141) | 1.87615624 |
| 144 | Hypoalphalipoproteinemia (HP:0003233) | 1.86668688 |
| 145 | Dysostosis multiplex (HP:0000943) | 1.83829711 |
| 146 | Hypoglycemic seizures (HP:0002173) | 1.83547514 |
| 147 | Abnormal platelet function (HP:0011869) | 1.82862127 |
| 148 | Impaired platelet aggregation (HP:0003540) | 1.82862127 |
| 149 | Abnormality of macrophages (HP:0004311) | 1.81802853 |
| 150 | Progressive neurologic deterioration (HP:0002344) | 1.80353129 |
| 151 | Metabolic acidosis (HP:0001942) | 1.79462248 |
| 152 | Abnormal cartilage morphology (HP:0002763) | 1.78465575 |
| 153 | Entropion (HP:0000621) | 1.78277221 |
| 154 | Agammaglobulinemia (HP:0004432) | 1.77909405 |
| 155 | Opisthotonus (HP:0002179) | 1.77078380 |
| 156 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.76798166 |
| 157 | Mucopolysacchariduria (HP:0008155) | 1.76798166 |
| 158 | Microcytic anemia (HP:0001935) | 1.76457592 |
| 159 | Hyperthyroidism (HP:0000836) | 1.72104864 |
| 160 | Orchitis (HP:0100796) | 1.71951976 |
| 161 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.71154128 |
| 162 | Muscle fiber atrophy (HP:0100295) | 1.70807905 |
| 163 | Rib fusion (HP:0000902) | 1.69437617 |
| 164 | Severe muscular hypotonia (HP:0006829) | 1.68334636 |
| 165 | Obstructive lung disease (HP:0006536) | 1.68133988 |
| 166 | Chronic obstructive pulmonary disease (HP:0006510) | 1.68133988 |
| 167 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.65342223 |
| 168 | IgG deficiency (HP:0004315) | 1.64701142 |
| 169 | Microvesicular hepatic steatosis (HP:0001414) | 1.62213635 |
| 170 | Acute hepatic failure (HP:0006554) | 1.61515926 |
| 171 | Brittle hair (HP:0002299) | 1.59406846 |
| 172 | Increased IgM level (HP:0003496) | 1.58940194 |
| 173 | Nasal polyposis (HP:0100582) | 1.56906476 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.02724577 |
| 2 | BCKDK | 3.99795421 |
| 3 | NME2 | 3.66351476 |
| 4 | VRK2 | 3.42944135 |
| 5 | FLT3 | 2.53478816 |
| 6 | MAP4K1 | 2.50856393 |
| 7 | PIM2 | 2.47525620 |
| 8 | BLK | 2.26227657 |
| 9 | TBK1 | 2.16300972 |
| 10 | TESK2 | 2.16226682 |
| 11 | KDR | 2.15517236 |
| 12 | STK16 | 2.04990894 |
| 13 | ZAP70 | 1.88174784 |
| 14 | MAP3K10 | 1.88048049 |
| 15 | PKN2 | 1.84004583 |
| 16 | MAP4K2 | 1.82942535 |
| 17 | EIF2AK3 | 1.72051913 |
| 18 | TYK2 | 1.69748882 |
| 19 | EPHB2 | 1.68730837 |
| 20 | LIMK1 | 1.68323645 |
| 21 | MAPKAPK3 | 1.66328649 |
| 22 | TRIB3 | 1.65450053 |
| 23 | EEF2K | 1.63721447 |
| 24 | BUB1 | 1.61369550 |
| 25 | SCYL2 | 1.60198192 |
| 26 | KIT | 1.54758833 |
| 27 | FGFR4 | 1.44659673 |
| 28 | LRRK2 | 1.42162282 |
| 29 | ZAK | 1.41793388 |
| 30 | MAP3K11 | 1.38393823 |
| 31 | BTK | 1.38235684 |
| 32 | IKBKE | 1.35953394 |
| 33 | NEK9 | 1.34660608 |
| 34 | WEE1 | 1.33777676 |
| 35 | RPS6KB2 | 1.32838848 |
| 36 | TESK1 | 1.29663944 |
| 37 | ICK | 1.26731406 |
| 38 | MAP3K14 | 1.26642639 |
| 39 | NUAK1 | 1.26299305 |
| 40 | IKBKB | 1.25935160 |
| 41 | PASK | 1.24172908 |
| 42 | IRAK4 | 1.20383107 |
| 43 | JAK3 | 1.17657302 |
| 44 | TEC | 1.17490981 |
| 45 | PIK3CG | 1.17471012 |
| 46 | SIK1 | 1.15894914 |
| 47 | SMG1 | 1.15354313 |
| 48 | WNK4 | 1.14553231 |
| 49 | ACVR1B | 1.14017426 |
| 50 | MAP2K2 | 1.12988972 |
| 51 | EIF2AK1 | 1.11678316 |
| 52 | MAP2K7 | 1.08894881 |
| 53 | MAP2K3 | 1.08187886 |
| 54 | RPS6KA4 | 1.07501053 |
| 55 | IRAK3 | 1.06908562 |
| 56 | TAOK3 | 1.03605350 |
| 57 | PIM1 | 1.02655149 |
| 58 | EPHA2 | 0.97595381 |
| 59 | GRK6 | 0.97146663 |
| 60 | CSF1R | 0.95289865 |
| 61 | MAP3K3 | 0.94757570 |
| 62 | RPS6KA5 | 0.94622122 |
| 63 | BRSK2 | 0.94395653 |
| 64 | TXK | 0.94214613 |
| 65 | INSRR | 0.91030046 |
| 66 | STK10 | 0.89435482 |
| 67 | DYRK3 | 0.88835616 |
| 68 | VRK1 | 0.87937312 |
| 69 | TAOK2 | 0.87296500 |
| 70 | DYRK2 | 0.86268869 |
| 71 | TNK2 | 0.85642565 |
| 72 | MAPK11 | 0.84881612 |
| 73 | TLK1 | 0.84040027 |
| 74 | TGFBR1 | 0.83960883 |
| 75 | PAK4 | 0.82834970 |
| 76 | PTK6 | 0.81591245 |
| 77 | ADRBK2 | 0.81431234 |
| 78 | SYK | 0.80154355 |
| 79 | HIPK2 | 0.76602729 |
| 80 | NME1 | 0.76387369 |
| 81 | MST1R | 0.75236072 |
| 82 | CDK19 | 0.75053037 |
| 83 | NEK2 | 0.74945976 |
| 84 | ARAF | 0.71914415 |
| 85 | CHUK | 0.70823257 |
| 86 | CSNK1G3 | 0.70729901 |
| 87 | MAP3K8 | 0.69715162 |
| 88 | ABL2 | 0.68249893 |
| 89 | SIK2 | 0.67049741 |
| 90 | LYN | 0.66484985 |
| 91 | TGFBR2 | 0.65554863 |
| 92 | MAPK15 | 0.63497876 |
| 93 | CDK4 | 0.61564275 |
| 94 | CDK7 | 0.60777190 |
| 95 | RPS6KA2 | 0.60467380 |
| 96 | DAPK1 | 0.60368870 |
| 97 | LMTK2 | 0.60013384 |
| 98 | NLK | 0.59881209 |
| 99 | ILK | 0.58005483 |
| 100 | BRAF | 0.57998483 |
| 101 | DYRK1B | 0.57431461 |
| 102 | ITK | 0.56876983 |
| 103 | PAK1 | 0.56261934 |
| 104 | RPS6KA6 | 0.55186978 |
| 105 | CHEK2 | 0.54974381 |
| 106 | IRAK1 | 0.53454840 |
| 107 | FES | 0.52948880 |
| 108 | PRKG2 | 0.52524467 |
| 109 | MST4 | 0.52323674 |
| 110 | MATK | 0.51247345 |
| 111 | IRAK2 | 0.51016958 |
| 112 | MAP2K6 | 0.50959160 |
| 113 | MUSK | 0.50881240 |
| 114 | CSK | 0.49546334 |
| 115 | ADRBK1 | 0.48361544 |
| 116 | LCK | 0.48067859 |
| 117 | AURKB | 0.47943849 |
| 118 | RPS6KC1 | 0.47411552 |
| 119 | RPS6KL1 | 0.47411552 |
| 120 | PDK2 | 0.44470976 |
| 121 | BMPR1B | 0.44070592 |
| 122 | RAF1 | 0.43689699 |
| 123 | CSNK1A1L | 0.43137196 |
| 124 | JAK2 | 0.42710715 |
| 125 | JAK1 | 0.42696659 |
| 126 | CDK8 | 0.42417762 |
| 127 | PRKD3 | 0.41245307 |
| 128 | AURKA | 0.40870300 |
| 129 | MAPKAPK2 | 0.39985176 |
| 130 | PRKCQ | 0.39571367 |
| 131 | MYLK | 0.39555811 |
| 132 | BRSK1 | 0.39425180 |
| 133 | STK4 | 0.36839560 |
| 134 | DAPK3 | 0.35212016 |
| 135 | BMX | 0.33853879 |
| 136 | PRKCD | 0.33782904 |
| 137 | MAPKAPK5 | 0.33679019 |
| 138 | MARK3 | 0.33306977 |
| 139 | EIF2AK2 | 0.33227321 |
| 140 | PRKCI | 0.32701453 |
| 141 | CSNK2A1 | 0.32033587 |
| 142 | ATR | 0.31958891 |
| 143 | EPHB1 | 0.30933956 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 2.64936974 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.55842937 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.27649572 |
| 4 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.24720053 |
| 5 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.18377039 |
| 6 | Huntingtons disease_Homo sapiens_hsa05016 | 2.09180904 |
| 7 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.98299304 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 1.97651977 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.92888835 |
| 10 | DNA replication_Homo sapiens_hsa03030 | 1.91849776 |
| 11 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.89770995 |
| 12 | Sulfur relay system_Homo sapiens_hsa04122 | 1.86829914 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.84667703 |
| 14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.84318817 |
| 15 | Alzheimers disease_Homo sapiens_hsa05010 | 1.78822663 |
| 16 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.77702547 |
| 17 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.76439296 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.76145926 |
| 19 | Protein export_Homo sapiens_hsa03060 | 1.73027514 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.67051647 |
| 21 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.62211058 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.53926771 |
| 23 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.53151671 |
| 24 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.51571289 |
| 25 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.50450034 |
| 26 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.50334644 |
| 27 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.44174421 |
| 28 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.42288310 |
| 29 | Mismatch repair_Homo sapiens_hsa03430 | 1.40388537 |
| 30 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.39739724 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.38122018 |
| 32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.37369170 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.35242772 |
| 34 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.34399690 |
| 35 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.34127539 |
| 36 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.32860530 |
| 37 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.32319944 |
| 38 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.32308813 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.27810441 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.27393352 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.27201362 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.24940388 |
| 43 | Carbon metabolism_Homo sapiens_hsa01200 | 1.24316661 |
| 44 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.23521381 |
| 45 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.22349070 |
| 46 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.20776088 |
| 47 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.20329681 |
| 48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.20274143 |
| 49 | Base excision repair_Homo sapiens_hsa03410 | 1.19936065 |
| 50 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.18599597 |
| 51 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.17016059 |
| 52 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.16840155 |
| 53 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.15706255 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.14955676 |
| 55 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.14280724 |
| 56 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.04388946 |
| 57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.04118175 |
| 58 | RNA polymerase_Homo sapiens_hsa03020 | 1.03825423 |
| 59 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.01768759 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.01278925 |
| 61 | Other glycan degradation_Homo sapiens_hsa00511 | 0.97889493 |
| 62 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.96790144 |
| 63 | Galactose metabolism_Homo sapiens_hsa00052 | 0.96204336 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.94395041 |
| 65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.94327723 |
| 66 | Legionellosis_Homo sapiens_hsa05134 | 0.92640339 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.89757519 |
| 68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88427462 |
| 69 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.87476975 |
| 70 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.86403492 |
| 71 | Asthma_Homo sapiens_hsa05310 | 0.84577705 |
| 72 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.83928767 |
| 73 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.83163591 |
| 74 | Retinol metabolism_Homo sapiens_hsa00830 | 0.82393963 |
| 75 | Allograft rejection_Homo sapiens_hsa05330 | 0.82121894 |
| 76 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.81400282 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.80356550 |
| 78 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.79793735 |
| 79 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.79738976 |
| 80 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79338581 |
| 81 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.77455433 |
| 82 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.77336457 |
| 83 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.74620358 |
| 84 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.74485766 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.70130586 |
| 86 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.69952538 |
| 87 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.69574749 |
| 88 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.69071222 |
| 89 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.68420766 |
| 90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.67858127 |
| 91 | Homologous recombination_Homo sapiens_hsa03440 | 0.67427137 |
| 92 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.62972674 |
| 93 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.62730452 |
| 94 | Metabolic pathways_Homo sapiens_hsa01100 | 0.62615988 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.62560778 |
| 96 | Spliceosome_Homo sapiens_hsa03040 | 0.59536984 |
| 97 | Shigellosis_Homo sapiens_hsa05131 | 0.58686936 |
| 98 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.58092184 |
| 99 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.57922695 |
| 100 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.57543303 |
| 101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.56429717 |
| 102 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.56344814 |
| 103 | Leishmaniasis_Homo sapiens_hsa05140 | 0.56326336 |
| 104 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.54904767 |
| 105 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54455321 |
| 106 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.54070050 |
| 107 | ABC transporters_Homo sapiens_hsa02010 | 0.53795376 |
| 108 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.53709369 |
| 109 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.53355231 |
| 110 | Salmonella infection_Homo sapiens_hsa05132 | 0.53118615 |
| 111 | Measles_Homo sapiens_hsa05162 | 0.52676337 |
| 112 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.52166487 |
| 113 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.52165077 |
| 114 | Lysosome_Homo sapiens_hsa04142 | 0.52076960 |
| 115 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.50558415 |
| 116 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.48678672 |
| 117 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.46617868 |
| 118 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.46247558 |
| 119 | Parkinsons disease_Homo sapiens_hsa05012 | 0.42150476 |
| 120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41037347 |
| 121 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.40534907 |
| 122 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.40087568 |
| 123 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.38917754 |
| 124 | Apoptosis_Homo sapiens_hsa04210 | 0.37731292 |
| 125 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.36911178 |
| 126 | Purine metabolism_Homo sapiens_hsa00230 | 0.35923504 |
| 127 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.34959161 |
| 128 | Influenza A_Homo sapiens_hsa05164 | 0.34061770 |
| 129 | Tuberculosis_Homo sapiens_hsa05152 | 0.28872994 |
| 130 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.27960951 |
| 131 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.27749477 |
| 132 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.27704731 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26296902 |
| 134 | Pertussis_Homo sapiens_hsa05133 | 0.26115812 |
| 135 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.23375429 |
| 136 | Basal transcription factors_Homo sapiens_hsa03022 | 0.22621902 |

